TNF and preeclampsia: Complement activation has also been shown to stimulate the release of tumor necrosis factor-alpha (TNF-ɑ) and soluble vascular endothelial growth factor receptor 1 (sVEGFR1) through leukocyte infiltration, both associated with alterations related to placental implantation and the development of preeclampsia [24,25].